https://vitalspanwire.com/news/survaxm-survive-glioblastoma-overall-survival-endpointVitalspan Wireen2026-10-09T21:01:38.042ZSurVaxM misses overall survival endpoint in glioblastoma trialhttps://vitalspanwire.com/news/fda-atezolizumab-adjuvant-stage-iii-dmmr-colon-cancerVitalspan Wireen2026-10-09T16:01:45.576ZFDA approves atezolizumab after surgery for stage III dMMR colon cancerhttps://vitalspanwire.com/news/dog-aging-body-size-epigenetic-aging-transposable-elementsVitalspan Wireen2026-10-09T11:01:44.564ZDog-aging study links larger body size to faster epigenetic aginghttps://vitalspanwire.com/news/cagrisema-redefine-3-cardiovascular-trial-designVitalspan Wireen2026-10-08T21:01:54.922ZCagriSema cardiovascular trial publishes design as outcome results remain pendinghttps://vitalspanwire.com/news/glucose-monitor-diabetes-long-term-kidney-markers-studyVitalspan Wireen2026-10-08T16:02:29.293ZGlucose-monitor study finds lasting blood-sugar gains, with kidney benefits still uncertainhttps://vitalspanwire.com/news/lipid-chain-length-aging-signal-across-speciesVitalspan Wireen2026-10-08T11:02:10.857ZLipid chain length emerges as an aging signal across species